Evidence map›Paper›PMID 37130356›Full record

ArticleMicrobiology spectrum2023

What's the Matter with MICs: Bacterial Nutrition, Limiting Resources, and Antibiotic Pharmacodynamics.

Brandon A Berryhill, Teresa Gil-Gil, Joshua A Manuel, Andrew P Smith, Ellie Margollis, Fernando Baquero, Bruce R Levin

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 37 citations in OpenAlex.

  1. Establishing communities of practice in undergraduate science classrooms.Journal of microbiology & biology education · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Uncertainty undermines the validity of antimicrobial pharmacodynamics.Journal of pharmacokinetics and pharmacodynamics · 2026
    Article
  7. Article
  8. Article
  9. Contrasting pH optima of β-lactamases CTX-M and CMY influenceApplied and environmental microbiology · 2026
    Article
  10. The role of innate immunity, antibiotics, and bacteriophages in the course of bacterial infections and their treatment.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Article
  12. Article
  13. L-Arabinose Alters theMicroorganisms · 2025
    Article
  14. Review
  15. Antibiotic killing of drug-induced bacteriostatic cells.Antimicrobial agents and chemotherapy · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Brandon A Berryhill *Department of Biology, Emory University, Atlanta, Georgia, USA.
Teresa Gil-Gil *Department of Biology, Emory University, Atlanta, Georgia, USA.
Joshua A ManuelDepartment of Biology, Emory University, Atlanta, Georgia, USA.
Andrew P SmithDepartment of Biology, Emory University, Atlanta, Georgia, USA.
Ellie MargollisDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Fernando BaqueroHospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, and Centro de Investigación Médica en Red, Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.ORCID 0000-0002-7930-3033
Bruce R LevinDepartment of Biology, Emory University, Atlanta, Georgia, USA.ORCID 0000-0003-3600-2780
Emory University · USConsejo Superior de Investigaciones Científicas · ESInstituto Ramón y Cajal de Investigación Sanitaria · ESSt. Jude Children's Research Hospital · US

Funding

Single Cell Analysis Core (Core C)U19AI158080 · NIAID · EMORY UNIVERSITY · PI LEVIN, BRUCE RICHARD · 2021 to 2025
$10.9M
Theoretical and Experimental Studies of the Population and Evolutionary Dynamics of Bacteria and Bacteriophage.R35GM136407 · NIGMS · EMORY UNIVERSITY · PI LEVIN, BRUCE RICHARD · 2020 to 2024
$2.0M
NIAID NIH HHS U19 AI158080NIGMS NIH HHS R35 GM136407
6 · The paper itself

Abstract

The MIC of an antibiotic required to prevent replication is used both as a measure of the susceptibility/resistance of bacteria to that drug and as the single pharmacodynamic parameter for the rational design of antibiotic treatment regimes. MICs are experimentally estimated

Indexed as

Anti-Bacterial AgentsEscherichia coliBacteriaMicrobial Sensitivity TestsModels, TheoreticalAnti-Bacterial Agentsantibiotic resistanceantibioticsheteroresistanceminimum inhibitory concentrationpharmacodynamicspopulation biology

Identifiers

PMID37130356
PMCPMC10269441
OpenAlexW4365450503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.